Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Indivior Pharmaceuticals (INDV) Other financing activities (2024)

Indivior Pharmaceuticals has reported Other financing activities over the past 1 years, most recently at -$1.0 million for Q1 2024.

  • Quarterly results put Other financing activities at -$1.0 million for Q1 2024, changed N/A from a year ago — trailing twelve months through Jun 2025 was -$1.0 million (changed N/A YoY), and the annual figure for FY2024 was $2.0 million, changed.
  • Other financing activities for Q1 2024 was -$1.0 million at Indivior Pharmaceuticals.
  • Over the last five years, Other financing activities for INDV hit a ceiling of -$1.0 million in Q1 2024 and a floor of -$1.0 million in Q1 2024.